Jonathan Couchman - 22 Nov 2024 Form 3 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Director
Signature
/s/ Jon Couchman
Issuer symbol
ENZ
Transactions as of
22 Nov 2024
Transactions value $
$0
Form type
3
Filing time
02 Dec 2024, 16:15:10
Previous filing
17 Aug 2021
Next filing
17 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENZ Common Stock 130K 22 Nov 2024 By Xstelos Holdings, Inc. F1
holding ENZ Common Stock 40K 22 Nov 2024 By Myrexis, Inc. F2
holding ENZ Common Stock 277K 22 Nov 2024 In retirement accounts F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are owned by Xstelos Holdings, Inc., of which the Reporting Person is the sole officer and controlling person. He controls a majority of the shares of Xstelos Holdings, Inc. through shares held in his personal Roth IRA retirement account and through shares held by Couchman Investments LP, a family investment fund, which he controls and which is owned by him and by a trust for the benefit of his children, of which he is the investment manager. The Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that the Reporting Person is a beneficial owner of the securities of the Issuer reported herein.
F2 Shares are owned by Myrexis, Inc., of which the Reporting Person is the sole officer and controlling person. Myrexis, Inc. is controlled by Xstelos Holdings, Inc. The Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that the Reporting Person is a beneficial owner of the securities of the Issuer reported herein.
F3 227,237 shares are held in the Reporting Person's personal SEP-IRA retirement account and 50,000 shares are held in the Reporting Person's personal 401(k) retirement account.

Remarks:

Power of Attorney